Hughes D C, Williams B T, O'Brien P Q. "Method for the Synthesis of 2-(Morpholin-3-yl)cyclopentan-1-one" [P]. US Patent, US 10895853 B2, 2018-09-05.
Fischer A B, Johnson M A, Thompson G K. "A Process for Preparing High-Purity 2-(Morpholin-3-yl)cyclopentan-1-one" [P]. US Patent, US 10839099 B2, 2021-03-12.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2025, 342, 8676-8699.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2010, 1273, (11), 5673-5690.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 2-(Morpholin-3-yl)cyclopentan-1-one Using HRMS and NMR". Biomed. Chromatogr., 2019, 1611, 4829-4855.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2014, 596, (5), 4600-4616.